Five-year follow-up after long plaque-bridging coronary arteriotomy for diffuse coronary artery disease

Thorac Cardiovasc Surg. 2003 Dec;51(6):318-21. doi: 10.1055/s-2003-45424.

Abstract

Long arteriotomy bridging a stenotic plaque or segment may improve runoff in diffuse coronary artery disease. However, patency might be impaired due to vascular wall pathology.

Objective: To determine the patency rates of plaque-bridging arteriotomy compared to conventional coronary artery bypass grafting.

Methods: Between May 1995 and December 1998, 104 patients with a mean age of 65 +/- 7 years received a long arteriotomy extending over a heavily plaqued area in an effort to treat their diffuse coronary artery disease. The length of the arteriotomy ranged from 14 mm to 40 mm. We retrospectively analyzed the intra-individual bypass graft patency rates by multidetector-computed tomography or coronary angiography.

Results: The mean follow-up was 5 years. There were 5 (4.8 %) early and 10 (9.6 %) late deaths, three non-cardiovascular. Graft patency for internal thoracic artery (ITA) to left anterior descending artery (LAD) (plaque-bridging) was 94.8 %, for saphenous vein graft (SVG) to circumflex artery (CX) (plaque-bridging) 67 %, and SVG to right coronary artery (RCA) (plaque-bridging) 79.5 %. Graft patency for ITA to LAD (conventional) was 94.9 %, for SVG to CX (conventional) 72.4 %, and SVG to RCA (conventional) 75 %. Freedom from angina was 82.8 % (n = 58/70), freedom from myocardial infarction was 95.7 % (n = 67/70), freedom from reintervention was 91.4 % (n = 64/70) and freedom from reoperation was 100 % (n = 70/70).

Conclusion: Diffuse coronary artery disease can be treated by extending the arteriotomy over the plaques, with graft patency rates comparable to bypass grafts onto less diseased segments.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Coronary Artery Bypass
  • Coronary Disease / epidemiology
  • Coronary Disease / physiopathology
  • Coronary Disease / surgery*
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Myocardial Revascularization / methods*
  • Retrospective Studies
  • Risk Factors
  • Vascular Patency